Novinky z webu

Is there an increased risk of developing de novo inflammatory bowel disease while under treatment with anti-TNF-alpha for other chronic inflammatory or immune-mediated diseases? Alimentary Pharmacology & Therapeutics [...]
St, sep 18, 2019
Medscape Allergy and Immunology
A cancer-causing compound banned by U.S. regulators last year as a food additive has been found at potentially dangerous levels in mint and menthol flavored e-cigarette liquids and smokeless tobacco products, researchers said on Monday. Reuters Health Information [...]
St, sep 18, 2019
Medscape Allergy and Immunology
A new B cell-depleting therapy, given as a monthly subcutaneous injection, has shown impressive results in two phase 3 studies in relapse-remitting multiple sclerosis. Medscape Medical News [...]
Po, sep 16, 2019
Medscape Allergy and Immunology
An FDA advisory panel recommended peanut allergen powder (Palforzia, Aimmune Therapeutics) for children aged 4 years through 17 years who are allergic to peanuts. Medscape Medical News [...]
Po, sep 16, 2019
Medscape Allergy and Immunology
U.S. health officials on Thursday cut the number of lung illnesses linked to e-cigarettes and vaping products under investigation to 380 as states began assessing patients based on a narrower case definition issued late last month by the Centers for Disease Control and Prevention (CDC). Reuters Health Information [...]
So, sep 14, 2019
Medscape Allergy and Immunology
Three medical stories that we didn't cover, explained. Medscape [...]
Pi, sep 13, 2019
Medscape Allergy and Immunology
A first of its kind observational study compares effectiveness of initial treatment choices for children and adolescents with multiple sclerosis — and finds an advantage for newer agents. Medscape Medical News [...]
Pi, sep 13, 2019
Medscape Allergy and Immunology
CDC researchers identified strategies used to decrease exposure to measles in outpatient facilities that lack negative-pressure rooms. Medscape Medical News [...]
Pi, sep 13, 2019
Medscape Allergy and Immunology
Angioedema is a potentially life-threatening condition that commonly presents to the ED. How is this condition best managed? Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health [...]
Pi, sep 13, 2019
Medscape Allergy and Immunology
Do homeless persons experience higher rates of RSV? What factors may contribute to the risk for these infections? Emerging Infectious Diseases [...]
Pi, sep 13, 2019
Medscape Allergy and Immunology
Inebilizumab is one of three new treatments for neuromyelitis optica — which have all shown striking degrees of efficacy — but are likely to be much more expensive than current mainstay therapy. Medscape Medical News [...]
Pi, sep 13, 2019
Medscape Allergy and Immunology
Nucala is the first biologic approved in the US for children aged 6 to 11 years with severe eosinophilic asthma. News Alerts [...]
Št, sep 12, 2019
Medscape Allergy and Immunology